Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome.

In an open randomized multicenter comparative study, we evaluated the safety and efficacy of cefepime (CP; 2.0 g given intravenously every 12 h) and ceftazidime (CZ; 2.0 g given intravenously every 8 h) as initial treatment for adult patients with suspected serious bacterial infections. A total of 1...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Kieft, H, Hoepelman, A I, Rozenberg-Arska, M, Branger, J M, Voskuil, J H, Geers, A B, Kluyver, M, Hart, H C, Poest-Clement, E, van Beugen, L
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1994
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284473/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8203833/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.3.415
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!